Food Yellow #3. The concentration of dye tested was 50 mg/ L of incubation mixture (25 pg/tube) in RIA systems for human lutropin (hLH), its alpha and beta subunits, rat LII, rat corticotropin (rACTH), rat insulin, and human thyroxin (T4) and testosterone. (For T4 we usedthe MAGIC-T4 RIAkit from Corning, Medfleld, MA 02052.) The testosterone RIA involved 3H-tracer and dextran-coated charcoal separation; all others had 'I-labeled tracers and double-antibody solid-phase separation.
of various Al standard solutions. We assayed these under the instrument conditions described by Brown et al., but reduced the step 3 temperature to 130 "C to eliminate spattering during the drying step.
There were no significant differences in the recovery of Al from uremic serum samples at 25, 50, or 100 pg/L final concentration of added Al, the mean analytical recovery (and range, n = 8) being 97% (93-112%), 100% (96-103%), and 97% (96-99%), respectively, expressed as a percentage of the recovery obtained for normal serum assayed by the same technique. The mean (and range) of endogenous Al present in the normal and uremic sera was 8 (6-12) and 30 (18-41) g/L, respectively. The uremic samples were all obtained from hemodialysis patients. The mean (and range) of urea values obtainedfor our uremic sera, in mmol/L, was 32.0 (17.0-45.0), the reference range 3.5-7. 5 .
We conclude that it is not necessary to precipitate proteins (3) or to extract the sample (4) for assays of Al in uremic serum to be reliable. We have explored the performance of the Bio-Rad DIAMAT HPLC chromatograph in the assay of glycated hemoglobins. The completely automated instrument carries a weak cation-exchange resin column; the support is silica with a carboxymethyl functional group.
For HbA1, imprecision in the series (n = 30), expressed as CV%, was 1.3% on a sample from a normal subject, and 0.5% on a sample from a diabetic patient; imprecision between series (n = 34) for similar samples was 3.7% and 2.3%, The interferent HbF can be separatedand quantified; the assay results vary linearly with HbF up to 50% of total Hb. HbF in excess of 3%, however, produces an apparent decrease of HbA1 results. The instrument also reveals the presence of HbS and calculates its peak area, and can therefore be used for screening both HbF and HbS.
Labile glycated hemoglobin is eliminated by incubating the hemolysate for 45 mm at room temperature. HbA1 and HbA1 readings are not significantly altered if sample hematocrit is artificially changed from an initial 75% all the way down to 15%. The reference intervals, determined from 105 normally distributed healthy subjects, are 4.4 to 6.0% for HbA1 and 5.5 to 7.1% for HbA,. We studied erythrocyte binding of theophylline in patients treated for at least two weeks, analyzing 17 samples before (serum) and after the extraction procedure (serum and erythrocytes). Mean ± SEM concentrations of serum and erythrocytic theophylline and the ratio of erythrocyte/ serum theophylline were, respectively: 11.04 ± 1.21 and 7.15 ± 0.74 mg/L, and 0695 ± 0.063. Our data indicate an erythrocytic binding of theophylline averaging 69.58% (SD 6.32), in agreement with those previously reported (Chin Chem 1985;31:1415-6), indicating that theophylhine binds to both erythrocytes and serum proteinsin approximately the same ratio.
However, recent results of our laboratory seem to indicate that the concentrations of drug in erythrocytes are greater than those of free drug in serum. We plan to clarify this particular point and to try to establish clinical correlations with values for total, free serum, or intra-erythrocytic theophylline.
C-Terminai Radiolmmunoassays for Parathyrin
Compared for the Diagnosis of Primary Hyperparathyroidism, Pedro Esbrit and Aurelio Rapado (Unidad Metab#{243}lica, FundaciOn Jim#{233}nez DIaz, Avda.
Reyes Cat#{233}hicos 2, 28040 Madrid, Spain)
The existence of various circulating forms of parathyrin (PTH) complicates the assay of this hormone. The heterogeneity of the results obtained with different RIAs (1) and the lack of an available standard have, until recently, impeded measurements of PTH in human serum. Because use of iodinated C-terminal fragments as tracers in RIAs for human P'FH (hPTH) improves assay performance (2), we have evaluated three different RIAs of C-terminal specificity to measure immunoreactive parathyrin (iPTH) in serum of 76 patients with surgically proved primary hyperparathyroidism.
In assay A we used purified bovine FF11 (bFFH) of the iPTH values obtained with assay A were within the normal range, two of these (7% of total) were from patients having normal calcemia ( 105 mg/L) on the day iPTH was determined.
The correlation coefficient between the concentrations of calcium and iFFH in serum from hyperparathyroid patients was higher for the homologous assay B (r = 0.72) than for the other assays (r = 0.5).
These results suggestthatan RIA for measuring FFH in human serum based on a synthetic carboxy-terminal fragment as tracer, especially if it contains a human sequence, might well be chosen as an aid for the diagnosis of primary hyperparathyroidism.
